Drugs / Nirmatrelvir/ritonavir
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06792214 | Jan 2025 → Jan 2026 overdue | long COVID-19 | Mount Sinai Hospital, Canada | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nirmatrelvir/ritonavir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06792214 ↗ |